BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 11795336)

  • 1. How should FDA regulate prescription drug promotion on the Internet?
    Opderbeck DW
    Food Drug Law J; 1998; 53(1):47-61. PubMed ID: 11795336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legal overview of likely FDA regulation of Internet promotion.
    Scheineson MJ
    Food Drug Law J; 1996; 51(4):697-716. PubMed ID: 11797736
    [No Abstract]   [Full Text] [Related]  

  • 3. Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.
    Reichertz PS
    Food Drug Law J; 1996; 51(3):355-65. PubMed ID: 11797712
    [No Abstract]   [Full Text] [Related]  

  • 4. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
    Kopp SW; Bang HK
    Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding government regulation of the marketing and advertising of medical devices, drugs, and biologics: the challenges of the Internet.
    Reichertz PS
    Food Drug Law J; 1997; 52(3):303-8. PubMed ID: 10343029
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical device labeling and advertising: an overview.
    Basile EM; Armentrout E; Reeves KN
    Food Drug Law J; 1999; 54(4):519-33. PubMed ID: 11824451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-prescribing medication: regulating prescription drug sales on the Internet.
    Yoo K
    John Marshall J Comput Inf Law; 2001; 20(1):57-89. PubMed ID: 16331879
    [No Abstract]   [Full Text] [Related]  

  • 8. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise and peril of direct-to-consumer prescription drug promotion on the Internet.
    Hall TS
    DePaul J Health Care Law; 2003; 7(1):1-41. PubMed ID: 15468476
    [No Abstract]   [Full Text] [Related]  

  • 10. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
    Leghorn J; Brophy E; Rother P
    Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulating drug promotion on the Internet.
    Bannon L
    Food Drug Law J; 1999; 54(4):599-621. PubMed ID: 11824457
    [No Abstract]   [Full Text] [Related]  

  • 12. Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisements.
    Kaphingst KA; Rudd RE; DeJong W; Daltroy LH
    Patient Educ Couns; 2004 Nov; 55(2):293-300. PubMed ID: 15530767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfing the Net in shallow waters: product liability concerns and advertising on the Internet.
    Moberg MA; Wood JW; Dorfman HL
    Food Drug Law J; 1998; 53(2):213-24. PubMed ID: 10346682
    [No Abstract]   [Full Text] [Related]  

  • 14. Major issues in marketing regulation.
    Pines WL
    Food Drug Law J; 1997; 52(3):297-302. PubMed ID: 10343028
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

  • 16. Is the information "fair and balanced" in direct-to-consumer prescription drug websites?
    Huh J; Cude BJ
    J Health Commun; 2004; 9(6):529-40. PubMed ID: 15764451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New challenges for medical product promotion and its regulation.
    Pines WL
    Food Drug Law J; 1997; 52(1):61-5. PubMed ID: 10346710
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct-to-consumer advertisements of prescription drugs.
    Council on Ethical and Judicial Affairs of the American Medical Association
    Food Drug Law J; 2000; 55(1):119-24. PubMed ID: 12322719
    [No Abstract]   [Full Text] [Related]  

  • 19. Food labeling: nutrient content claims, expansion of the nutrient content claim "lean". Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Jan; 72(8):1455-9. PubMed ID: 17294560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which prescription for the illegible and unreadable DTC (direct-to-consumer) brief summary--major surgery or euthanasia?
    Hochhauser M
    Manag Care Q; 2002; 10(3):6-10. PubMed ID: 12476659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.